Skip to main content
PMC home page
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 2004 Sep;81(3):401–415. doi: 10.1093/jurban/jth126

An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men

Spencer Lieb 1,✉, Samuel R Friedman 1, Dale D Chitwood 2, Thomas M Liberti 1, Gary J Gates 1, Lisa R Metsch 2, Lorene M Maddox 1, Tamara Kuper 2
PMCID: PMC3455939  PMID: 15273264

Abstract

Issues of cost and complexity have limited the study of the population sizes of men who have sex with men (MSM) and injection drug users (IDUs), two groups at clearly increased risk for human immunodeficiency virus (HIV) and other acute and chronic diseases. We developed a prototypical, easily applied estimation model for these populations and applied it to Miami, Florida. This model combined HIV prevalence estimates, HIV seroprevalence rates, and census data to make plausible estimates of the number and proportion of MSM and IDUs under a number of assumptions. Sensitivity analyses were conducted to test the robustness of the model. The model suggests that approximately 9.5% (plausible range 7.7%–11.3%) of Miami males aged 18 years or older are MSM (point estimate, N=76,500), and 1.4% (plausible range 0.9%–1.9%) of the total population aged 18 years or older are IDUs (point estimate, N=23,700). Males may be about 2.5 times more likely than females to be IDUs. The estimates were reasonably robust to biases. The model was used to develop MSM and IDU population estimates in selected urban areas across Florida and should be replicable in other medium-to-large urban areas. Such estimates could be useful for behavioral surveillance and resource allocation, including enhanced targeting of community-based interventions for primary and secondary HIV prevention.

Keywords: Epidemic modeling, Infection drug users, HIV prevalence, HIV/AIDS, Men who have sex with men

Full Text

The Full Text of this article is available as a PDF (137.5 KB).

Footnotes

Dr. Friedman is with National Development Research Institutes, Inc.

Dr. Gates is with the Urban Institute.

References

  • 1.Binson D, Michaels S, Stall R, Gagnon J, Coates T, Catania J. Prevalence and social distribution of men who have sex with men: United States and its urban centers. J Sex Res. 1995;32:245–254. [Google Scholar]
  • 2.Blair JA. A probability sample of gay urban males: the use of two-phase adaptive sampling. J Sex Res. 1999;36:39–44. [Google Scholar]
  • 3.Catania JA, Osmond D, Stall RD, et al. The continuing HIV epidemic among men who have sex with men. Am J Public Health. 2001;91:907–914. doi: 10.2105/ajph.91.6.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Davies AG, Cormack RM, Richardson AM. Estimation of injecting drug users in the City of Edinburgh, Scotland, and number infected with human immunodeficiency virus. Int J Epidemiol. 1999;28:117–121. doi: 10.1093/ije/28.1.117. [DOI] [PubMed] [Google Scholar]
  • 5.Fay RE, Turner CF, Klassen AS, Gagnon H. Prevalence and patterns of same-gender sexual contact among men. Science. 1989;243:338–348. doi: 10.1126/science.2911744. [DOI] [PubMed] [Google Scholar]
  • 6.Frischer M, Leyland A, Cormack R, et al. Estimating the population prevalence of injection drug use and infection with human immunodeficiency virus among injection drug users in Glasgow, Scotland. Am J Epidemiol. 1993;138:170–181. doi: 10.1093/oxfordjournals.aje.a116843. [DOI] [PubMed] [Google Scholar]
  • 7.Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;86:642–654. doi: 10.2105/AJPH.86.5.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Pisani E. Estimating the size of populations at risk for HIV: issues and methods. A joint UNAIDS/IMPACT/Family Health International workshop: report and conclusions. May 2002. Available at: http://webjka.dph.gov.my/aids/HighRiskEstimate/HighRiskEstimate.pdf. Accessed February 24, 2003.
  • 9.Centers for Disease Control and Prevention HIV/STD Risks in young men who have sex with men who do not disclose their sexual orientation—six U.S. cities, 1994–2000. MMWR Morb Mortal Wkly Rep. 2003;52:81–85. [PubMed] [Google Scholar]
  • 10.Rogers SM, Turner CF. Male-male sexual contact in the USA: findings from five sample surveys, 1970–1990. J Sex Res. 1991;28:491–519. doi: 10.1080/00224499109551621. [DOI] [Google Scholar]
  • 11.Archibald CP, Jayaraman GC, Major C, Patrick DM, Houston SM, Sutherland D. Estimating the size of hard-to-reach populations: a novel method using HIV testing data compared to other methods. AIDS. 2001;15(suppl 3):S41–S48. doi: 10.1097/00002030-200104003-00006. [DOI] [PubMed] [Google Scholar]
  • 12.Brown BS, Beschner GM, editors. Handbook on Risk of AIDS: Injection Drug Users and Sexual Partners. Westport, CT: Greenwood Press; 1993. [Google Scholar]
  • 13.Wright D, Gfroerer J, Epstein J. Ratio estimation of hardcore drug use. Journal of Official Statistics. 1997;13:401–416. [Google Scholar]
  • 14.Friedman SR, Perlis TE, Jarlais DC. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence and HIV incidence. Am J Public Health. 2001;91:791–793. doi: 10.2105/ajph.91.5.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Friedman SR, Perlis T, Lynch J, Jarlais DC. Economic inequality, poverty, and laws against syringe access as predictors of metropolitan area rates of drug injection and HIV infection. In: NIDA, editor. 2000 Global Research Network Meeting on HIV Prevention in Drug-Using Populations. Third Annual Meeting Report. Durban, South Africa, July 5–7, 2000. Washington, DC: US Department of Health and Human Services; 2001. pp. 72–75. [Google Scholar]
  • 16.Adult HIV/AIDS Confidential Case Report. Atlanta, GA: Centers for Disease Control and Prevention. Form CDC 50.42A, rev. 01/2003:1.
  • 17.Green TA. Using surveillance data to monitor trends in the AIDS epidemic. Stat Med. 1998;17:143–154. doi: 10.1002/(SICI)1097-0258(19980130)17:2<143::AID-SIM757>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
  • 18.Fleming PL, Byers RH, Sweeney PA, Daniels D, Karon JM, Janssen RS. HIV prevalence in the United States, 2000 [abstract 11]. Ninth Conference on Retroviruses and Opportunistic Infections. February 25, 2002, Atlanta, GA. Available at: http://63.126.3.84/2002/Abstract/13996.htm. Accessed February 25, 2002.
  • 19.Centers for Disease Control and Prevention. Characteristics of persons living with HIV and AIDS, 2001. HIV/AIDS Surveill Suppl Rep. 2003;9(2): Available at: http://www.cdc.gov/hiv/stats/hasrsuppVol9No2.htm. Accessed July 12, 2003.
  • 20.Chitwood DD, Sanchez J, Comerford M, Page JB, McBride DC, Kitner KR. First injection and current risk factors for HIV among new and long-term injection drug users. AIDS Care. 2000;12:313–320. doi: 10.1080/09540120050042972. [DOI] [PubMed] [Google Scholar]
  • 21.Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Probl. 1989;36:416–423. [Google Scholar]
  • 22.Carlson RG, Wang J, Siegal HA, Falk RS, Guo J. An ethnographic approach to targeted sampling: problems and solutions in AIDS prevention research among injection drug and crack-cocaine users. Hum Organ. 1994;53:279–286. [Google Scholar]
  • 23.Nwanyanwu OC, Conti LA, Ciesielski CA, et al. Increasing frequency of heterosexually transmitted AIDS in South Florida: artifact or reality? Am J Public Health. 1993;83:571–573. doi: 10.2105/ajph.83.4.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Lee LM, McKenna MT, Janssen RS. Classification of transmission of risk in the national HIV/AIDS surveillance system. Public Health Rep. 2003;118:400–407. doi: 10.1016/S0033-3549(04)50271-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Klevins RM, Fleming PL, Neal JJ, Li J. Is there really a heterosexual AIDS epidemic in the United States? Findings from a multi-site validation study, 1992–1995. Am J Epidemiol. 1999;149:75–84. doi: 10.1093/oxfordjournals.aje.a009730. [DOI] [PubMed] [Google Scholar]
  • 26.Webster RD, Darrow WW, Paul JP, Roark RA, Woods WJ, Stempel RR. HIV infection and associated risks among young men who have sex with men in a Florida resort community. J Acquir Immune Defic Syndr. 2003;33:223–231. doi: 10.1097/00126334-200306010-00018. [DOI] [PubMed] [Google Scholar]
  • 27.Laumann EO, Gagnon JH, Michael RT, Michaels S. The Social Organization of Sexuality: Sexual Practices in the United States. Chicago: University of Chicago Press; 1994. [Google Scholar]
  • 28.McCoy CB, Chitwood DD, Khoury EL, Miles CE. The implementation of an experimental research design in the evaluation of an intervention to prevent AIDS among IV drug users. J Drug Issues. 1990;20:215–222. [Google Scholar]
  • 29.Ciesielski CA. Sexually transmitted diseases in men who have sex with men: an epidemiologic review. Curr Infect Dis Rep. 2003;5:145–152. doi: 10.1007/s11908-003-0051-5. [DOI] [PubMed] [Google Scholar]
  • 30.Valleroy LA, MacKellar DA, Karon JM, et al. HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group. JAMA. 2000;284:198–204. doi: 10.1001/jama.284.2.198. [DOI] [PubMed] [Google Scholar]
  • 31.Jarlais DC, Dehne K, Casabona J. HIV surveillance among injecting drug users. AIDS. 2001;15(suppl 3):S13–S22. doi: 10.1097/00002030-200104003-00003. [DOI] [PubMed] [Google Scholar]
  • 32.McFarland W, Caceres CF. HIV surveillance among men who have sex with men. AIDS. 2001;15(suppl 3):S23–S32. doi: 10.1097/00002030-200104003-00004. [DOI] [PubMed] [Google Scholar]
  • 33.Chitwood DD, Comerford M, McCoy HV. Satisfaction with access to health care among injection drug users, other drug users and nonusers. J Behav Health Serv Res. 2002;29:189–197. doi: 10.1007/BF02287705. [DOI] [PubMed] [Google Scholar]
  • 34.Chitwood DD, McCoy CB, Comerford M, Kitner KR. The prevalence and incidence of HIV among injection drug users: a 5 year panel study. Popul Res and Policy Rev. 1999;18:39–53. doi: 10.1023/A:1006148711071. [DOI] [Google Scholar]
  • 35.McCoy HV, Chitwood DD, Page JB, McCoy CB. Skills for HIV risk reduction: evaluation of recall and performance in injecting drug users. Subst Use Misuse. 1997;32:229–247. doi: 10.3109/10826089709055848. [DOI] [PubMed] [Google Scholar]
  • 36.Black D, Gates G, Taylor L, Sanders S. Demographics of the gay and lesbian population in the United States: evidence from available systematic data sources. Demography. 2000;37:139–154. [PubMed] [Google Scholar]
  • 37.Friedman SR, Tempalski B, Perlis T, et al. Estimating numbers of IDUs in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for IDUs. J Urban Health. 2004;81:377–400. doi: 10.1093/jurban/jth125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Centers for Disease Control and Prevention. Youth risk behavior surveillance system. 2001. Available at: http://apps.nccd.cdc.gov/YRBSS/index.asp. Accessed July 8, 2003.
  • 39.Kaplan EH, Soloshatz D. How many drug injectors are there in New Haven? Answers from AIDS data. Math Comput Model. 1993;17:109–115. doi: 10.1016/0895-7177(93)90243-R. [DOI] [Google Scholar]
  • 40.Aldrich MR, Mandel J, Newmeyer JA. A spreadsheet for AIDS: estimating heterosexual injection drug user population size from AIDS statistics in San Francisco. J Psychoactive Drugs. 1990;22:343–349. doi: 10.1080/02791072.1990.10472558. [DOI] [PubMed] [Google Scholar]
  • 41.Frischer M, Bloor M, Finlay A, et al. A new method of estimating prevalence of injecting drug use in an urban population: results from a Scottish city. Int J Epidemiol. 1991;20:997–1000. doi: 10.1093/ije/20.4.997. [DOI] [PubMed] [Google Scholar]
  • 42.Hook EB, Regal RR. Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev. 1995;17:243–264. doi: 10.1093/oxfordjournals.epirev.a036192. [DOI] [PubMed] [Google Scholar]
  • 43.Wright D, Gfroerer J, Epstein J. The use of external data sources and ratio estimation to improve estimates of hardcore drug use from the NHSDA. NIDA Res Monogr. 1997;167:477–497. [PubMed] [Google Scholar]
  • 44.Frischer M, Hickman M, Kraus L, Mariani F, Wiessing L. A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain. Addiction. 2001;96:1465–1476. doi: 10.1046/j.1360-0443.2001.9610146510.x. [DOI] [PubMed] [Google Scholar]
  • 45.Karon JM, Khare M, Rosenberg PS. The current status of methods for estimating the prevalence of human immunodeficiency virus in the United States of America. Stat Med. 1998;17:127–142. doi: 10.1002/(SICI)1097-0258(19980130)17:2<127::AID-SIM756>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
  • 46.Zeni MB, Lieb S. MSM and IDU estimates: an evaluation. Florida Department of Health, 2003. Available at: www.doh.state.fl.us/disease_ctrl/aids/trends/trends.html. Accessed August 14, 2003.
  • 47.National HIV Prevalence Surveys, 1997 Summary. Atlanta, GA: Centers for Disease Control and Prevention; 1998. pp. 1–25. [Google Scholar]
  • 48.HIV Prevalence Trends in Selected Populations in the United States: Results From National Serosurveillance, 1993–1997. Atlanta, GA: Centers for Disease Control and Prevention; 2001. pp. 1–51. [Google Scholar]
  • 49.Gallagher KM, Sullivan PS, Onorato I. A national system for HIV behavioral surveillance in the United States. 2003 National HIV Prevention Conference; July 28, 2003; Atlanta, GA. Conference program abstract M 3-B0801.
  • 50.Janssen RS, Holtgrave DR, Valdiserri RO, Shepherd M, Gayle HD, Cock KM. The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. Am J Public Health. 2001;91:1019–1024. doi: 10.2105/ajph.91.7.1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Centers for Disease Control and Prevention Advancing HIV prevention: new strategies for a changing epidemic—United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:329–332. [PubMed] [Google Scholar]
  • 52.Centers for Disease Control and Prevention Primary and secondary syphilis among men who have sex with men—New York City, 2001. MMWR Morb Mortal Wkly Rep. 2002;51:854–856. [PubMed] [Google Scholar]
  • 53.Fox KK, Rio C, Holmes KK, et al. Gonorrhea in the HIV era: a reversal in trends among men who have sex with me. Am J Public Health. 2001;91:907–914. doi: 10.2105/ajph.91.6.959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Friedman SR, Flom PL, Kottiri BJ, et al. Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City. Addiction. 2003;98:159–169. doi: 10.1046/j.1360-0443.2003.00271.x. [DOI] [PubMed] [Google Scholar]
  • 55.Ochnio JJ, Patrick D, Ho M, Talling DN, Dobson SR. Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs. CMAJ. 2001;165:293–297. [PMC free article] [PubMed] [Google Scholar]
  • 56.Cotter SM, Sansom S, Long T, et al. Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies. J Infect Dis. 2003;187:1235–1240. doi: 10.1086/374057. [DOI] [PubMed] [Google Scholar]
  • 57.Kahn J. Preventing hepatitis A and hepatitis B virus infections among men who have sex with men. Clin Infect Dis. 2002;35:1382–1387. doi: 10.1086/343044. [DOI] [PubMed] [Google Scholar]
  • 58.Novick DM, Haverkos HW, Teller DW, et al. The medically ill substance abuser. In: Lowinson JH, Ruiz P, Millman RB, et al., editors. Substance Abuse: a Comprehensive Textbook. 3rd ed. Baltimore, MD: Williams and Wilkins; 1997. pp. 534–550. [Google Scholar]
  • 59.Centers for Disease Control and Prevention Hepatitis B vaccination for injection drug users—Pierce County, Washington, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:388–390. [PubMed] [Google Scholar]
  • 60.Alter MJ, Moyer LA. The importance of preventing hepatitis C virus infection among injection drug users in the United States. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl 1):S6–S10. doi: 10.1097/00042560-199802001-00003. [DOI] [PubMed] [Google Scholar]
  • 61.Samuel MC, Doherty PM, Bulterys M, Jenison SA. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect. 2001;127:475–484. doi: 10.1017/S0950268801006197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Bastos FI, Barcellos C, Lowndes CM, Friedman SR. Co-infection with malaria and HIV injecting drug users in Brazil: a new challenge to public health? Addiction. 1999;94:1165–1174. doi: 10.1046/j.1360-0443.1999.94811656.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES